Controlled breathing added to exercise for people with multiple myeloma

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In this randomized, parallel, double-blind trial, adults with active multiple myeloma receiving daratumumab will be assigned to either therapeutic exercise with breathing education alone or with an additional home breathing protocol for 6 weeks. All participants will complete on-site and home exercise sessions, step or activity targets, and assessments before, after, and 4 weeks post-intervention. The study aims to see if the breathing program provides added benefits to cardiorespiratory variables beyond exercise and education alone.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years.
* Confirmed diagnosis of multiple myeloma, currently undergoing active treatment with daratumumab, and under clinical follow-up by the Hematology Department of HU12O.
* Explicit medical indication for supervised physical activity issued by the responsible hematologist and documented in the medical record.
* No scheduled hematopoietic stem cell transplantation within the 60 days following the planned start date of the intervention (verified through medical record review).
* Functional status of ECOG 0-2 (Eastern Cooperative Oncology Group), assessed by a healthcare professional from the Hematology Department, ensuring the ability to perform at least basic and light instrumental activities of daily living, including independent ambulation.
* Access to a smartphone with stable internet connection, required for monitoring and recording adherence to the intervention.
* Ability to provide written informed consent, demonstrating understanding of the study's nature, purpose, and procedures.

Exclusion Criteria:

* Medical risk contraindicating exercise or breathing techniques:

  * Clinically significant cardiovascular disease, including:decompensated heart failure, acute myocardial infarction within the past 3 months, clinically uncontrolled arrhythmias, unstable angina, acute-phase deep vein thrombosis or pulmonary embolism, pacemakers or cardiac devices whose monitoring parameters contraindicate supervised exercise according to cardiology.
  * Severe decompensated respiratory disease, such as acute exacerbation of COPD, severe respiratory insufficiency, or persistently low resting oxygen saturation \< 90% (not correctable).
* High musculoskeletal or bone risk:

  * Extensive lytic bone lesions, high risk of pathological fracture, or unstable vertebral fracture, documented by imaging or based on the assessment of the Hematology/Traumatology specialist.
  * Uncontrolled pain that prevents safe participation in an exercise program.
* Hematologic or systemic conditions contraindicating exercise:

  * Severe anemia: hemoglobin \< 9 g/dL in women or \< 8 g/dL in men (latest laboratory test ≤ 14 days).
  * Active systemic infection contraindicating exercise, fever ≥ 38 °C, or neutropenia \< 0.5 × 10⁹/L.
  * Severe cytopenias that, in the opinion of the hematologist, preclude moderate exercise.
* Functional or procedural limitations:

  * Inability to remain in the supine position for ≥ 5 minutes, required for part of the breathing intervention.
  * Confirmed pregnancy or reasonable suspicion of pregnancy.
  * Severe cognitive impairment, major psychiatric disorders, or neurological diseases that limit understanding of the procedures or safe participation.
  * Significant difficulty understanding the language (spoken or written) that prevents following essential instructions or completing validated questionnaires.

Where it's running

• Hospital Universitario 12 de Octubre
  Madrid, Spain Recruiting

Study contacts

• Study coordinator: Isidro Fernández-López, PhD
• Email: isidrofe@ucm.es
• Phone: +34625598970

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Controlled breathing added to therapeutic exercise in multiple myeloma

  This trial tests whether adding a home-based controlled breathing program to a therapeutic exercise plan helps reduce somatic symptoms in adults with multiple myeloma.

  Recruiting Universidad Complutense de Madrid · Madrid · NCT07312942

• Breathwork for older adults after knee replacement

  This study tests whether a quick, at-home breathwork activity can help adults 65 and older recover better after knee replacement surgery.

  Recruiting University of Arizona · Tucson, Arizona · NCT07464860

• Heart Rate Variability Changes and Delirium After Major Abdominal Surgery

  This study looks at whether early changes in resting heart rate variability can signal the development of postoperative delirium in older adults after major abdominal surgery.

  Recruiting The First Affiliated Hospital with Nanjing Medical University · Nanjing, Jiangsu · NCT07783464

• Cognitive changes after BCMA CAR-T in multiple myeloma

  This study tests whether cognitive function changes over time in adults with relapsed or refractory multiple myeloma who receive BCMA CAR-T therapy.

  Recruiting Wake Forest University Health Sciences · Charlotte, North Carolina · NCT07740317

• How movement and nervous system function relate after stroke

  This study tests whether measures of movement efficiency and nerve function relate to outcomes in adults who had a stroke.

  Recruiting University of California, Davis · Sacramento, California · NCT07737873

• Heart rate variability feedback to help practitioners make better patient decisions

  This study tests whether giving healthcare workers HRV feedback during care improves how quickly and safely they respond to ventilator events and bedside needs.

  Recruiting Papworth Hospital NHS Foundation Trust · Cambridge, Cambridgeshire · NCT07709364

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.